X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Merck Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs TEVA PHARMA (Israel) - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MERCK   TEVA PHARMA
EQUITY SHARE DATA
    MERCK
Dec-17
TEVA PHARMA
Dec-13
MERCK/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,3582,897-   
Low Rs9332,517-   
Sales per share (Unadj.) Rs665.01,662.7-  
Earnings per share (Unadj.) Rs56.6103.9-  
Cash flow per share (Unadj.) Rs72.5238.3-  
Dividends per share (Unadj.) Rs15.0090.93-  
Dividend yield (eoy) %1.33.4 39.0%  
Book value per share (Unadj.) Rs441.71,847.0-  
Shares outstanding (eoy) m16.60848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.6 105.8%   
Avg P/E ratio x20.226.1 77.7%  
P/CF ratio (eoy) x15.811.4 139.1%  
Price / Book Value ratio x2.61.5 176.9%  
Dividend payout %26.587.5 30.3%   
Avg Mkt Cap Rs m19,0112,295,528 0.8%   
No. of employees `0001.544.9 3.4%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.031,371.6 22.8%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.21,959.8 31.0%   
INCOME DATA
Net Sales Rs m11,0401,409,995 0.8%  
Other income Rs m2400-   
Total revenues Rs m11,2791,409,995 0.8%   
Gross profit Rs m1,376386,128 0.4%  
Depreciation Rs m264113,971 0.2%   
Interest Rs m027,695 0.0%   
Profit before tax Rs m1,352244,462 0.6%   
Minority Interest Rs m01,111 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170-160,476 -0.1%   
Tax Rs m583-2,985 -19.5%   
Profit after tax Rs m93988,081 1.1%  
Gross profit margin %12.527.4 45.5%  
Effective tax rate %43.1-1.2 -3,531.0%   
Net profit margin %8.56.2 136.2%  
BALANCE SHEET DATA
Current assets Rs m7,523952,305 0.8%   
Current liabilities Rs m2,253830,491 0.3%   
Net working cap to sales %47.78.6 552.6%  
Current ratio x3.31.1 291.3%  
Inventory Days Days5291 57.4%  
Debtors Days Days4196 42.3%  
Net fixed assets Rs m1,240460,535 0.3%   
Share capital Rs m1663,471 4.8%   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,3331,566,237 0.5%   
Long term debt Rs m0720,962 0.0%   
Total assets Rs m9,9123,222,290 0.3%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.10.4 254.5%   
Return on assets %9.53.6 263.7%  
Return on equity %12.85.6 227.7%  
Return on capital %20.84.9 420.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m537224,680 0.2%  
From Investments Rs m-476-79,613 0.6%  
From Financial Activity Rs m-220-269,519 0.1%  
Net Cashflow Rs m-160-124,452 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.41 Rs / USD

Compare MERCK With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare MERCK With: BIOCON   WOCKHARDT  SHASUN PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Indian Indices Continue Downtrend; Sensex Ends 495 Points Lower(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Apr 22, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS